Skip Navigation

Receive this page by email each issue: [Sign up for eTOCs]

Cover Image
Other Issues:
Previous
Contents: Volume 19, Number 6, June 2008   [Index by Author] 

Down in this issue
Down editorials
Down reviews
Down original articles
     lung cancer
     breast cancer
     gastrointestinal tumors
     hematologic malignancies
     epidemiology
     melanoma
Down letters


[Search ALL Issues]


Front Matter (PDF) | Table of Contents (PDF)

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

in this issue Back

In this issue
Ann Oncol 2008 19: 1031; doi:10.1093/annonc/mdn380 [Extract] [Full Text] [PDF] [Request Permissions]  

editorials Back

J. Baselga and H.-J. Senn
The perspective and role of the medical oncologist in cancer prevention: A position paper by the European Society for Medical Oncology
Ann Oncol 2008 19: 1033-1035; doi:10.1093/annonc/mdn366 [Extract] [Full Text] [PDF] [Request Permissions]  

D. N. Hayes and H. L. McLeod
EGFR regulation by microRNA in lung cancer: a rose by any other name ... is an increasingly complicated rose
Ann Oncol 2008 19: 1036-1037; doi:10.1093/annonc/mdn357 [Extract] [Full Text] [PDF] [Request Permissions]  

reviews Back

S. H. Yang, K. H. Yang, Y. P. Li, Y. C. Zhang, X. D. He, A. L. Song, J. H. Tian, L. Jiang, Z. G. Bai, L. F. He, Y. L. Liu, and B. Ma
Breast conservation therapy for stage I or stage II breast cancer: a meta-analysis of randomized controlled trials
Annals of Oncology Advance Access published on January 10, 2008
Ann Oncol 2008 19: 1039-1044; doi:10.1093/annonc/mdm573 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

N. F. Aykan and E. Idelevich
The role of UFT in advanced gastric cancer
Annals of Oncology Advance Access published on February 14, 2008
Ann Oncol 2008 19: 1045-1052; doi:10.1093/annonc/mdn024 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

original articles Back

lung cancer Back

G. J. Weiss, L. T. Bemis, E. Nakajima, M. Sugita, D. K. Birks, W. A. Robinson, M. Varella-Garcia, P. A. Bunn, Jr, J. Haney, B. A. Helfrich, H. Kato, F. R. Hirsch, and W. A. Franklin
EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines
Annals of Oncology Advance Access published on February 27, 2008
Ann Oncol 2008 19: 1053-1059; doi:10.1093/annonc/mdn006 [Abstract] [Full Text] [PDF] [Supplementary Data] [Request Permissions]  

A. Yada, M. Yazawa, S. Ishida, H. Yoshida, K. Ichikawa, S. Kurakata, and K. Fujiwara
A novel humanized anti-human death receptor 5 antibody CS-1008 induces apoptosis in tumor cells without toxicity in hepatocytes
Annals of Oncology Advance Access published on February 27, 2008
Ann Oncol 2008 19: 1060-1067; doi:10.1093/annonc/mdn015 [Abstract] [Full Text] [PDF] [Request Permissions]  

breast cancer Back

H. J. Burstein, A. M. Storniolo, S. Franco, J. Forster, S. Stein, S. Rubin, V. M. Salazar, and K. L. Blackwell
A phase II study of lapatinib monotherapy in chemotherapy-refractory HER2-positive and HER2-negative advanced or metastatic breast cancer
Annals of Oncology Advance Access published on February 17, 2008
Ann Oncol 2008 19: 1068-1074; doi:10.1093/annonc/mdm601 [Abstract] [Full Text] [PDF] [Request Permissions]  

P. M. McGowan, E. McKiernan, F. Bolster, B. M. Ryan, A. D. K. Hill, E. W. McDermott, D. Evoy, N. O'Higgins, J. Crown, and M. J. Duffy
ADAM-17 predicts adverse outcome in patients with breast cancer
Annals of Oncology Advance Access published on January 30, 2008
Ann Oncol 2008 19: 1075-1081; doi:10.1093/annonc/mdm609 [Abstract] [Full Text] [PDF] [Request Permissions]  

A. R. Zander, C. Schmoor, N. Kröger, W. Krüger, V. Möbus, N. Frickhofen, B. Metzner, W. E. Berdel, M. Koenigsmann, E. Thiel, H. Wandt, K. Possinger, R. Kreienberg, M. Schumacher, and W. Jonat
Randomized trial of high-dose adjuvant chemotherapy with autologous hematopoietic stem-cell support versus standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: overall survival after 6 years of follow-up
Annals of Oncology Advance Access published on February 27, 2008
Ann Oncol 2008 19: 1082-1089; doi:10.1093/annonc/mdn023 [Abstract] [Full Text] [PDF] [Request Permissions]  

M. Untch, R. D. Gelber, C. Jackisch, M. Procter, J. Baselga, R. Bell, D. Cameron, M. Bari, I. Smith, B. Leyland-Jones, E. de Azambuja, P. Wermuth, R. Khasanov, F. Feng-yi, C. Constantin, J. I. Mayordomo, C.-H. Su, S.-Y. Yu, A. Lluch, E. Senkus-Konefka, C. Price, F. Haslbauer, T. Suarez Sahui, V. Srimuninnimit, M. Colleoni, A. S. Coates, M. J. Piccart-Gebhart, A. Goldhirsch, and for the HERA Study Team
Estimating the magnitude of trastuzumab effects within patient subgroups in the HERA trial
Annals of Oncology Advance Access published on February 21, 2008
Ann Oncol 2008 19: 1090-1096; doi:10.1093/annonc/mdn005 [Abstract] [Full Text] [PDF] [Request Permissions]  

A. Vazquez-Martin, C. Oliveras-Ferraros, R. Colomer, J. Brunet, and J. A. Menendez
Low-scale phosphoproteome analyses identify the mTOR effector p70 S6 kinase 1 as a specific biomarker of the dual-HER1/HER2 tyrosine kinase inhibitor lapatinib (Tykerb®) in human breast carcinoma cells
Annals of Oncology Advance Access published on February 17, 2008
Ann Oncol 2008 19: 1097-1109; doi:10.1093/annonc/mdm589 [Abstract] [Full Text] [PDF] [Request Permissions]  

Y. Belkacémi, J. Gligorov, M. Ozsahin, H. Marsiglia, B. De Lafontan, H. Laharie-Mineur, L. Aimard, E.-C. Antoine, B. Cutuli, M. Namer, and D. Azria
Concurrent trastuzumab with adjuvant radiotherapy in HER2-positive breast cancer patients: acute toxicity analyses from the French multicentric study
Annals of Oncology Advance Access published on March 15, 2008
Ann Oncol 2008 19: 1110-1116; doi:10.1093/annonc/mdn029 [Abstract] [Full Text] [PDF] [Request Permissions]  

gastrointestinal tumors Back

S. Collette, F. Bonnetain, X. Paoletti, M. Doffoel, O. Bouché, J. L. Raoul, P. Rougier, F. Masskouri, L. Bedenne, and J. C. Barbare
Prognosis of advanced hepatocellular carcinoma: comparison of three staging systems in two French clinical trials
Annals of Oncology Advance Access published on February 25, 2008
Ann Oncol 2008 19: 1117-1126; doi:10.1093/annonc/mdn030 [Abstract] [Full Text] [PDF] [Request Permissions]  

L. B. J. van Iersel, H. Gelderblom, A. L. Vahrmeijer, E. L. van Persijn van Meerten, F. G. J. Tijl, H. Putter, H. H. Hartgrink, P. J. K. Kuppen, J. W. R. Nortier, R. A. E. M. Tollenaar, and C. J. H. van de Velde
Isolated hepatic melphalan perfusion of colorectal liver metastases: outcome and prognostic factors in 154 patients
Annals of Oncology Advance Access published on February 27, 2008
Ann Oncol 2008 19: 1127-1134; doi:10.1093/annonc/mdn032 [Abstract] [Full Text] [PDF] [Request Permissions]  

J. Jeong, H.-C. Jeung, S. Y. Rha, C. K. Im, S. J. Shin, J. B. Ahn, S. H. Noh, J. K. Roh, and H. C. Chung
Phase II study of combination chemotherapy of 5-fluorouracil, low-dose leucovorin, and oxaliplatin (FLOX regimen) in pretreated advanced gastric cancer
Annals of Oncology Advance Access published on February 13, 2008
Ann Oncol 2008 19: 1135-1140; doi:10.1093/annonc/mdn013 [Abstract] [Full Text] [PDF] [Request Permissions]  

P. Pfeiffer, D. Nielsen, J. Bjerregaard, C. Qvortrup, M. Yilmaz, and B. Jensen
Biweekly cetuximab and irinotecan as third-line therapy in patients with advanced colorectal cancer after failure to irinotecan, oxaliplatin and 5-fluorouracil
Annals of Oncology Advance Access published on February 14, 2008
Ann Oncol 2008 19: 1141-1145; doi:10.1093/annonc/mdn020 [Abstract] [Full Text] [PDF] [Request Permissions]  

S. H. Cheon, S. Y. Rha, H.-C. Jeung, C.-K. Im, S. H. Kim, H. R. Kim, J. B. Ahn, J. K. Roh, S. H. Noh, and H. C. Chung
Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastases
Annals of Oncology Advance Access published on February 27, 2008
Ann Oncol 2008 19: 1146-1153; doi:10.1093/annonc/mdn026 [Abstract] [Full Text] [PDF] [Request Permissions]  

C. Qvortrup, M. Yilmaz, D. Ogreid, A. Berglund, L. Balteskard, J. Ploen, T. Fokstuen, H. Starkhammar, H. Sørbye, K. Tveit, and P. Pfeiffer
Chronomodulated capecitabine in combination with short-time oxaliplatin: a Nordic phase II study of second-line therapy in patients with metastatic colorectal cancer after failure to irinotecan and 5-flourouracil
Annals of Oncology Advance Access published on February 14, 2008
Ann Oncol 2008 19: 1154-1159; doi:10.1093/annonc/mdn002 [Abstract] [Full Text] [PDF] [Request Permissions]  

hematologic malignancies Back

A. Palumbo, F. Gay, S. Bringhen, A. Falcone, N. Pescosta, V. Callea, T. Caravita, F. Morabito, V. Magarotto, M. Ruggeri, I. Avonto, P. Musto, N. Cascavilla, B. Bruno, and M. Boccadoro
Bortezomib, doxorubicin and dexamethasone in advanced multiple myeloma
Annals of Oncology Advance Access published on March 6, 2008
Ann Oncol 2008 19: 1160-1165; doi:10.1093/annonc/mdn018 [Abstract] [Full Text] [PDF] [Request Permissions]  

C. Hosing, R. M. Saliba, G.-J. Okoroji, U. Popat, D. Couriel, T. Ali, L. De Padua Silva, P. Kebriaei, A. Alousi, M. De Lima, M. Qazilbash, P. Anderlini, S. Giralt, R. E. Champlin, and I. Khouri
High-dose chemotherapy and autologous hematopoietic progenitor cell transplantation for non-Hodgkin's lymphoma in patients >65 years of age
Annals of Oncology Advance Access published on February 13, 2008
Ann Oncol 2008 19: 1166-1171; doi:10.1093/annonc/mdm608 [Abstract] [Full Text] [PDF] [Request Permissions]  

A. O. Abdalla, P. Kokhaei, L. Hansson, H. Mellstedt, and A. Österborg
Idiotype vaccination in patients with myeloma reduced circulating myeloma cells (CMC)
Annals of Oncology Advance Access published on February 13, 2008
Ann Oncol 2008 19: 1172-1179; doi:10.1093/annonc/mdn017 [Abstract] [Full Text] [PDF] [Request Permissions]  

epidemiology Back

M.-C. Chen, I.-J. Feng, C.-H. Lu, C.-C. Chen, J.-T. Lin, S.-H. Huang, and K.-D. Lee
The incidence and risk of second primary cancers in patients with nasopharyngeal carcinoma: a population-based study in Taiwan over a 25-year period (1979–2003)
Annals of Oncology Advance Access published on January 30, 2008
Ann Oncol 2008 19: 1180-1186; doi:10.1093/annonc/mdn003 [Abstract] [Full Text] [PDF] [Request Permissions]  

C. Héry, J. Ferlay, M. Boniol, and P. Autier
Quantification of changes in breast cancer incidence and mortality since 1990 in 35 countries with Caucasian-majority populations
Annals of Oncology Advance Access published on March 5, 2008
Ann Oncol 2008 19: 1187-1194; doi:10.1093/annonc/mdn025 [Abstract] [Full Text] [PDF] [Request Permissions]  

melanoma Back

C. Garbe, P. Radny, R. Linse, R. Dummer, R. Gutzmer, J. Ulrich, R. Stadler, M. Weichenthal, TK. Eigentler, U. Ellwanger, and A. Hauschild
Adjuvant low-dose interferon {alpha}2a with or without dacarbazine compared with surgery alone: a prospective-randomized phase III DeCOG trial in melanoma patients with regional lymph node metastasis
Annals of Oncology Advance Access published on February 14, 2008
Ann Oncol 2008 19: 1195-1201; doi:10.1093/annonc/mdn001 [Abstract] [Full Text] [PDF] [Request Permissions]  

letters Back

H. Harputluoglu and K. Altundag
How can we use anthracylines in the management of newly diagnosed metastatic breast cancer patients overexpressing HER-2?
Annals of Oncology Advance Access published on March 28, 2008
Ann Oncol 2008 19: 1203; doi:10.1093/annonc/mdn152 [Extract] [Full Text] [PDF] [Request Permissions]  

M. M. J. Beckers, J. F. Verzijlbergen, M. M. C. van Buul, M. H. Prins, and D. H. Biesma
The potential role of positron emission tomography in the detection of occult cancer in 25 patients with venous thromboembolism
Annals of Oncology Advance Access published on April 2, 2008
Ann Oncol 2008 19: 1203-1204; doi:10.1093/annonc/mdn156 [Extract] [Full Text] [PDF] [Request Permissions]  

I. Spoormans, S. Altintas, J. Van den Brande, A. Luijks, and J. B. Vermorken
Purpura in a patient with disseminated breast cancer: a rapidly progressive cancer-related thrombotic thrombocytopenic purpura
Annals of Oncology Advance Access published on April 11, 2008
Ann Oncol 2008 19: 1204-1207; doi:10.1093/annonc/mdn160 [Extract] [Full Text] [PDF] [Request Permissions]  

R. Lacalamita, M. Schirone, and A. Paradiso
ISO 9001:2000 applied to a research oncology laboratory: which problems? The experience of National Cancer Institute-Bari
Annals of Oncology Advance Access published on April 25, 2008
Ann Oncol 2008 19: 1207-1208; doi:10.1093/annonc/mdn175 [Extract] [Full Text] [PDF] [Request Permissions]  

G. van Schoor, M. J. M. Broeders, E. Paap, J. D. M. Otten, G. J. den Heeten, and A. L. M. Verbeek
A rationale for starting breast cancer screening under age 50
Annals of Oncology Advance Access published on April 29, 2008
Ann Oncol 2008 19: 1208-1209; doi:10.1093/annonc/mdn177 [Extract] [Full Text] [PDF] [Request Permissions]  

M. Milella, G. Metro, A. Gelibter, S. M. Pino, F. Cognetti, and A. Fabi
COX-2 targeting in cancer: a new beginning?
Annals of Oncology Advance Access published on May 13, 2008
Ann Oncol 2008 19: 1209-1210; doi:10.1093/annonc/mdn286 [Extract] [Full Text] [PDF] [Request Permissions]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.